Acadia Pharmaceuticals Inc
ACAD· Nasdaq
ACADAcadia Pharmaceuticals Inc
Released May 1, 2019, after the close
10-Q filed May 2, 2019, 32 days after period end · 0001564590-19-014909
| Metric | Q1 2019 | Q1 2018 | Q1 2017 | Q1 2016 |
|---|---|---|---|---|
| Revenue | $62.96M | $48.87M | $15.29M | $4.00K |
| Net Income | -$85.30M | -$54.30M | -$87.84M | -$49.76M |
| EPS Diluted |
Acadia Pharmaceuticals Inc · CIK 1070494 · Engraved from SEC EDGAR
| -$0.59 |
| -$0.44 |
| -$0.72 |
| -$0.45 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
